Analysis of the Global Human Albumin Market and Product Pipeline
Analysis of the Global Human Albumin Market and Product Pipeline
Emerging Economies and Use of Human Albumin as an Excipient Present New Growth Opportunities
RELEASE DATE
02-Sep-2015
02-Sep-2015
REGION
Asia Pacific
Asia Pacific
Research Code: MB53-01-00-00-00
SKU: LS00110-AP-MR_16951
$4,950.00
In stock
SKU
LS00110-AP-MR_16951
Description
The study covers provides an assessment of the marketed and pipeline products for the global human albumin market. Segmentation by application has been provided along with additional information such as clinical trial timelines and results, and historical and projected launch timelines. The marketed and pipeline products have been broadly segmented into those used in replacement therapy (fluid-volume replacement therapy), in drug formulation and delivery, as stabilisers for vaccines, and as excipients in imaging and in-vitro fertilisation products. The market shares of the key companies operating in this space have also been listed.
Table of Contents
Executive Summary—Key Findings
Executive Summary—Key Findings (continued)
Key Trends
Key Companies to Watch
Methodology and Scope
Market Overview—Introduction
Market Overview—Blood Plasma Production
Blood Plasma Market Share
Demand Analysis of Blood Plasma Proteins
Human Albumin Production
Market Forecast—Human Albumin
Market Forecast—Human Albumin Discussion
Supply Chain and Distribution Network
Supply Chain and Distribution Network (continued)
Porter’s 5 Forces Analysis
Porter’s 5 Forces Analysis (continued)
Porter’s 5 Forces Analysis (continued)
Human Albumin Market Share Analysis
Market Segmentation
Recommendations for Data Center Operators
Competitive Landscape—Marketed and Pipeline Products
Marketed Products—Replacement Therapy
Marketed Products—Replacement Therapy (continued)
Pipeline Products—Replacement Therapy
Marketed Products—Drug Formulation and Delivery
Marketed Products—Drug Formulation and Delivery (continued)
Pipeline Products—Drug Formulation and Delivery
Marketed Products—Vaccine
Pipeline Products—Vaccine
Marketed Products—Others
Total Human Albumin Market—Major Ongoing/Recently Completed Clinical Trials
Summary of Key Products to Watch
Timeline of Key Events—Launch of Products
Product Dashboard: Albuminar—CSL Behring
Product Dashboard: Albutein—Grifols
Product Dashboard: Abraxane—Celgene
Product Dashboard: Victoza—Novo Nordisk
Product Dashboard: Recombumin—Novozymes
Product Dashboard: rIX-FP—CSL Behring
Conclusions
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition: Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Related Research
Popular Topics
The infectious disease IVD market in Indonesian presents diversified growth potential for different tiers of participants. Domestic participants stand to gain from the growth momentum in the lower-end market, whereas foreign leading manufacturers dominate the higher-end market. This research service analyses the infectious disease IVD market and provides an in-depth analysis of revenue forecast by segment, drivers and restraints, and technology trends, along with the competitive factors and strategies. The infectious disease IVD market in Indonesia can be divided into segments such as microbiology testing, immunochemistry testing, and molecular diagnostics testing. The study covers the period 2012 to 2017.
No Index | No |
---|---|
Podcast | No |
Author | Sriram Radhakrishnan |
WIP Number | MB53-01-00-00-00 |
Keyword 1 | Human albumin |
Keyword 2 | albumin |
Is Prebook | No |